DK143437C - Fremgangsmaade til fremstilling af en vaccine til hindring af sygdomme fremkaldt af katteleukaemivirus - Google Patents

Fremgangsmaade til fremstilling af en vaccine til hindring af sygdomme fremkaldt af katteleukaemivirus

Info

Publication number
DK143437C
DK143437C DK489874A DK489874A DK143437C DK 143437 C DK143437 C DK 143437C DK 489874 A DK489874 A DK 489874A DK 489874 A DK489874 A DK 489874A DK 143437 C DK143437 C DK 143437C
Authority
DK
Denmark
Prior art keywords
kateleukaemivirus
vaccine
prevention
procedure
preparation
Prior art date
Application number
DK489874A
Other languages
English (en)
Other versions
DK143437B (da
DK489874A (da
Inventor
W F H Jarrett
J O Jarrett
L J Mackey
Original Assignee
Univ Glasgow
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Glasgow filed Critical Univ Glasgow
Publication of DK489874A publication Critical patent/DK489874A/da
Publication of DK143437B publication Critical patent/DK143437B/da
Application granted granted Critical
Publication of DK143437C publication Critical patent/DK143437C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/464838—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
    • A61K2239/31—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterized by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
    • A61K2239/38—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/819—Viral vaccine for feline species, e.g. cats

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK489874A 1973-09-18 1974-09-17 Fremgangsmaade til fremstilling af en vaccine til hindring af sygdomme fremkaldt af katteleukaemivirus DK143437C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB43642/73A GB1486186A (en) 1973-09-18 1973-09-18 Vaccines against feline leukaemia and the group of diseases associated with feline leukaemis/virus infection
GB4364273 1973-09-18

Publications (3)

Publication Number Publication Date
DK489874A DK489874A (da) 1975-05-20
DK143437B DK143437B (da) 1981-08-24
DK143437C true DK143437C (da) 1981-12-28

Family

ID=10429675

Family Applications (1)

Application Number Title Priority Date Filing Date
DK489874A DK143437C (da) 1973-09-18 1974-09-17 Fremgangsmaade til fremstilling af en vaccine til hindring af sygdomme fremkaldt af katteleukaemivirus

Country Status (11)

Country Link
US (1) US3966907A (da)
JP (1) JPS5726484B2 (da)
BE (1) BE820042A (da)
CA (1) CA1039187A (da)
CH (1) CH609091A5 (da)
DE (1) DE2444299A1 (da)
DK (1) DK143437C (da)
FR (1) FR2243702B1 (da)
GB (1) GB1486186A (da)
NL (1) NL7412352A (da)
SE (1) SE421268B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4086134A (en) * 1973-09-18 1978-04-25 University Of Glasgow Method for preparation of vaccine against feline leukemia
US4034081A (en) * 1973-09-18 1977-07-05 University Of Glasgow Vaccines against feline leukemia
US4264587A (en) * 1979-08-01 1981-04-28 Pedersen Niels C Vaccine for preventing persistent feline leukemia viremia in cats
US4332793A (en) * 1979-12-18 1982-06-01 The Ohio State University Research Foundation Method of recovering cell antigen and preparation of feline leukemia vaccine therefrom
US4933179A (en) * 1983-08-22 1990-06-12 Syntex (U.S.A.) Inc. Feline leukemia virus antigen vaccines
US5152982A (en) * 1984-03-26 1992-10-06 Chiron Corporation Compositions and methods for FeLV vaccination
US4876089A (en) * 1984-09-06 1989-10-24 Chiron Corporation Feline leukemia virus protein vaccines
US5306493A (en) * 1986-10-03 1994-04-26 Miles Inc. FeLV-infected feline cell line
US5374424A (en) * 1986-10-03 1994-12-20 Miles Inc. Multivalent felv-infected feline vaccine
CA2005311C (en) * 1988-12-13 2006-05-30 Edward A. Hoover Prototype felv isolates for use in disease models and vaccines
US9783785B2 (en) 2010-12-20 2017-10-10 Cameron K. Tebbi Screening methods for detection of susceptibility to leukemia and lymphomas

Also Published As

Publication number Publication date
CH609091A5 (da) 1979-02-15
US3966907A (en) 1976-06-29
CA1039187A (en) 1978-09-26
FR2243702A1 (da) 1975-04-11
FR2243702B1 (da) 1977-11-04
JPS5726484B2 (da) 1982-06-04
DK143437B (da) 1981-08-24
DE2444299A1 (de) 1975-04-10
SE421268B (sv) 1981-12-14
SE7411672L (da) 1975-03-19
GB1486186A (en) 1977-09-21
DK489874A (da) 1975-05-20
BE820042A (fr) 1975-03-18
NL7412352A (nl) 1975-03-20
AU7336174A (en) 1976-03-25
JPS50116629A (da) 1975-09-12

Similar Documents

Publication Publication Date Title
NO145273C (no) N-formyl-alfa-l-aspartyl-l-fenylalanin for anvendelse til fremstilling av alfa-l-aspartyl-l-fenylalaninalkylestere
DK145676C (da) Analogifremgangsmaade til fremstilling af oxoalkyldialkylxanthiner
DK143437C (da) Fremgangsmaade til fremstilling af en vaccine til hindring af sygdomme fremkaldt af katteleukaemivirus
RO70474A (ro) PROCEDEU PENTRU PREPARAREA PARAXILENULёI
DK148282C (da) Fremgangsmaade til fremstilling af alkalimetalinsulin
DK132892C (da) Analogifremgangsmade til fremstilling af 4-aminoquinazoliner
IT1004348B (it) Procedimento per la preparazione di un polimero fotosensibile
DK155314C (da) Fremgangsmaade til fremstilling af xylitol
DK547475A (da) Fremgangsmade til fremstilling af 8,8-disubstituerede 6-methylergoliner
TR17584A (tr) Herbisid triazinlerinin hazirlanmasina mahsus usul
DK143173C (da) Fremgangsmaade til fremstilling af et urinstof-urinstofphosphatholdigt droevtyggerfoder
DK136249C (da) Analogifremgangsmade til fremstilling af xanthenderivater
DK144270C (da) Analogifremgangsmaade til fremstilling af n-carbamoyl-2-phenylethensulfonamider
DK137388B (da) Analogifremgangsmade til fremstilling af et pyrazinoisoquinolinderivat
DK137924C (da) Fremgangsmaade til fremstilling af 1,4-dihydroquinoliner
NO141410C (no) Analogifremgangsmaate til fremstilling av beta-adrenergisk blokkerende aminopropanoler
DK133950C (da) Fremgangsmade til fremstilling af halogenholdige tertiere phosphinoxider
DK142578A (da) Analogifremgangsmaade til fremstilling af 4-benzazininderivater
DK131943C (da) Fremgangsmade til fremstilling af 17beta-oxalylsteroider
DK133303C (da) Analogifremgangsmade til fremstilling af digitoxinorthoformiater
DK134756C (da) Analogifremgangsmade til fremstilling af 1-alkyl-2-(pyridylthiomethyl)-5-nitro-imidazoler savel som 1-alkyl-2-(n-oxypyridylthiomethyl)-5-nitro-imidazoler
DK134560C (da) Fremgangsmade til fremstilling af 6alfa-fluor-11beta-hydroksysteroider
DK124576A (da) Fremgangsmade til fremstilling af benzalicykliske forbindelser
DK370776A (da) Fremgangsmade til fremstilling af d-xylofuranosederivater
DK370876A (da) Fremgangsmade til fremstilling af d-xylofuranosederivater

Legal Events

Date Code Title Description
PBP Patent lapsed